PUBLICATION
LIST
原著論文 *Corresponding author, †Co-first author
Total 85報、First/Corresponding author 46報
2024（4）
Kaji K, Motegi T, Yonezawa T, Momoi Y, Maeda S*. Anti-tumor effects of lapatinib on HER2-positive canine prostatic carcinoma cell lines. Open Veterinary Journal. 2024; in press
Nakazawa M, Tochinai R, Fujii W, Komori M, Yonezawa T, Momoi Y, Maeda S*. Protective role of protease-activated receptor-2 in anaphylaxis model mice. PLoS One. 2024; 19(4):e0283915
Yokota S, Yonezawa T, Momoi Y, Maeda S*. Myeloid derived suppressor cells in peripheral blood can be a prognostic factor in canine transitional cell carcinoma. Veterinary Immunology and Immunopathology. 2024; 269:110716
Sato S, Hori K, Tanabe G, Maeda S, Momoi Y, Yonezawa T. Effect of diazoxide on a cat with insulinoma. JFMS Open Reports. 2024; 10(1):20551169231220290
2023（7）
Maeda S*. Second era of molecular-targeted cancer therapies in dogs. Journal of Veterinary Medical Science. 2023; 85(8): 790–798: Veterinary Science Award Winner's (No.132) Commemorative Review
Shitamori F, Nonogaki A, Motegi T, Matsumoto Y, Sakamoto M, Tanizawa Y, Nakamura Y, Yonezawa T, Momoi Y, Maeda S*. Large-scale epidemiological study on feline autosomal dominant polycystic kidney disease and identification of novel PKD1 gene variants. Journal of Feline Medicine and Surgery. 2023; 25(7):1098612X231185393
Yokota S, Kaji K, Yonezawa T, Momoi Y, Maeda S*. CD204⁺ tumor-associated macrophages are associated with clinical outcome in canine pulmonary adenocarcinoma and transitional cell carcinoma. The Veterinary Journal. 2023; 296-297:105992
Yoshida S, Maeda S, Yonezawa T, Motegi T*. Evaluation of antiseizure medications including zonisamide in feline idiopathic epilepsy at a referral hospital in Japan. Open Veterinary Journal. 2023; 13(7): 846-853
Yonezawa T*, Marasigan C, Matsumiya Y, Maeda S, Motegi T, Momoi Y. Effects of high-dose docosahexaenoic acid supplementation as an add-on therapy for canine idiopathic epilepsy: A pilot study. Open Veterinary Journal. 2023; 13(7): 942-947
Nishi R, Harada A, Hori K, Maeda S, Momoi Y, Yonezawa T*. 8-Hydroxy-2'-deoxyguanosine and malondialdehyde in plasma and their association with disease severity in 20 cats with chronic kidney disease. Journal of Feline Medicine and Surgery. 2023; 25(6):1098612X231173519
Uchida M, Matsumiya Y, Tsuboi M, Uchida K, Nakagawa T, Fujii W, Kobayashi T, Tsujimoto H, Ohmi A, Tomiyasu H, Motegi T, Maeda S, Momoi Y, Yonezawa T*. Serum level of apoptosis inhibitor of macrophage in dogs with histiocytic sarcoma and its association with the disease. Veterinary and Comparative Oncology. 2023; 21(3):391-400
2022（9）
Maeda S*, Motegi T, Iio A, Kaji K, Goto-Koshino Y, Eto S, Ikeda N, Nakagawa T, Nishimura R, Yonezawa T, Momoi Y. Anti-CCR4 treatment depletes regulatory T cells and leads to clinical activity in a canine model of advanced prostate cancer. Journal for ImmunoTherapy of Cancer. 2022;10:e003731 (プレスリリース①, ②、報道①, ②, ③, ④, ⑤, ⑥)
Maeda S*, Sakai K, Kaji K, Iio A, Nakazawa M, Motegi T, Yonezawa T, Momoi Y. Lapatinib as first-line treatment for muscle-invasive urothelial carcinoma in dogs. Scientific Reports. 2022; 12(1):4 (プレスリリース、報道①, ②)
Kaji K, Yonezawa T, Momoi Y, Maeda S*. Detection of Canine Urothelial Carcinoma Cells in Urine Using 5-Aminolevulinic Acid. Animals. 2022; 12(4):485 (ジャーナルの表紙に掲載)
Nishi R, Uchida M, Nakahara M, Maeda S, Hayashi A, Iwatani N, Tanaka T, Yonezawa T*. Adverse effect of repeated treatment with 5-aminoleveuic acid in healthy cats and those with chronic kidney disease. ALA-Porphyrin Science. 2022; 11(1):1-12
Hirose Y, Uchida M, Tsuboi M, Nakagawa T, Yaga L, Maeda S, Momoi Y, Kuriki Y, Kamiya M, Urano Y, Yonezawa T*. Rapid visualization of mammary gland tumor lesions of dogs using the enzyme-activated fluorogenic probe; γ-glutamyl hydroxymethyl rhodamine green. Journal of Veterinary Medical Science. 2022; 84(4):593-599
Yokota S, Yonezawa T, Momoi Y, Maeda S*. Sorafenib inhibits tumor cell growth and angiogenesis in canine transitional cell carcinoma. Journal of Veterinary Medical Science. 2022; 84(5):666-674
Kida T, Yamazaki A, Nakamura T, Kobayashi K, Yoshimoto S, Maeda S, Nakagawa T, Nishimura R, Murata T*. Comprehensive profiling of lipid metabolites in urine of canine patients with liver mass. Journal of Veterinary Medical Science. 2022; 84(8):1074-1078
Kida T, Yamazaki A, Nakamura T, Kobayashi K, Yoshimoto S, Maeda S, Nakagawa T, Nishimura R, Murata T*. Urinary lipid production profile in canine patients with splenic mass. Journal of Veterinary Medical Science. 2022; 84(11):1480-1484
Kim H, Yonezawa T*, Maeda S, Tamahara S, Matsuki N. Increases in serum carbonylated protein levels of dogs with hypercortisolism. Endocrine Journal. 2022; 69(12):1387-1394
2021（6）
Maeda S*, Yoshitake R, Chambers JK, Uchida K, Eto S, Ikeda N, Nakagawa T, Nishimura R, Goto-Koshino Y, Yonezawa T, Momoi Y. BRAF(V595E) Mutation Associates CCL17 Expression and Regulatory T Cell Recruitment in Urothelial Carcinoma of Dogs. Veterinary Pathology. 2021; 58(5):971-980
Yamazaki J*, Matsumoto Y, Jelinek J, Ishizaki T, Maeda S, Watanabe K, Ishihara G, Yamagishi J, Takiguchi M. DNA methylation landscape of 16 canine somatic tissues by methylation-sensitive restriction enzyme-based next generation sequencing. Scientific Reports. 2021;11(1):10005.
Sakai K, Chambers JK, Uchida K, Nakagawa T, Nishimura R, Yonezawa T, Maeda S*. ErbB2 copy number gain is associated with adverse outcome in canine mammary carcinoma. Journal of Veterinary Medical Science. 2021; 83(3):370-377
Nishi R, Motegi T, Maeda S, Tamahara S, Momoi Y, Matsuki N, Yonezawa T*. Clinical assessment of testosterone analogues for urethral sphincter mechanism incompetence in ten spayed female dogs. Journal of Veterinary Medical Science. 2021; 83(2):274-279
Sakai K, Shinohara Y, Kaji K, Yonezawa T, Momoi Y, Maeda S*. Human epidermal growth factor receptor 2 is overexpressed in canine prostate carcinoma. Translational and Regulatory Science. 2021; 3(1):1-8
Kaji K, Kaji N, Hori M, Sakai K, Yonezawa T, Maeda S*. Protease-activated receptor-2 is associated with adverse outcomes in canine mammary carcinoma. Veterinary Pathology. 2021; 58(1):53-62
2020（4）
Maeda S*, Nakazawa M, Uchida M, Yoshitake R, Nakagawa T, Nishimura R, Miyamoto R, Bonkobara M, Yonezawa T, Momoi Y. Foxp3+ Regulatory T Cells Associated With CCL17/CCR4 Expression in Carcinomas of Dogs. Veterinary Pathology. 2020; 57(4):497-506
Iio A, Kaji K, Kaji N, Hori M, Yonezawa T, Momoi Y, Maeda S*. Expression analysis of protease-activated receptor-2 in cats. Veterinary Immunology and Immunopathology. 2020; 229:110115
Sakai K, Maeda S*, Saeki K, Yoshitake R, Goto-Koshino Y, Nakagawa T, Nishimura R, Yonezawa T, Matsuki N. ErbB2 copy number aberration in canine urothelial carcinoma detected by a digital polymerase chain reaction assay. Veterinary Pathology. 2020; 57(1):56-65
Iio A, Maeda S, Yonezawa T, Momoi Y, Motegi T*. Isolated growth hormone deficiency in a Chihuahua with a GH1 mutation. Journal of Veterinary Diagnostic Investigation. 2020; 32(5):733-736
2019（8）
Maeda S*, Murakami K, Inoue A, Yonezawa T, Matsuki N. CCR4 Blockade Depletes Regulatory T cells and Prolongs Survival in a Canine Model of Bladder Cancer. Cancer Immunology Research. 2019; 7(7):1175-1187 (プレスリリース、報道)
Nakazawa M, Maeda S*, Yokoyama N, Nakagawa T, Yonezawa T, Ohno K, Matsuki N. Sphingosine-1-phosphate (S1P) signaling regulates the production of intestinal IgA and its potential role in the pathogenesis of canine inflammatory bowel disease. Journal of Veterinary Medical Science. 2019; 81(9):1249-1258 (2019年JVMS優秀論文賞)
Konishi K, Igarashi H*, Maeda S, Uchida E, Hanazono K, Tamamoto T, Uchida K, Endoh D, Ohno K. Distribution of regulatory T cells in inflammatory colorectal polyps of Miniature Dachshunds. Veterinary Immunology and Immunopathology. 2019; 218:109938
Eto S, Saeki K*, Yoshitake R, Yoshimoto S, Shinada M, Ikeda N, Kamoto S, Tanaka Y, Kato D, Maeda S, Tsuboi M, Chambers JK, Uchida K, Nishimura R, Nakagawa T. Anti-tumor effects of the histone deacetylase inhibitor vorinostat on canine urothelial carcinoma cells. PLoS One. 2019; 14(6):e0218382
Uchida M, Uchida K, Maeda S, Yonezawa T*. Expression of apoptosis inhibitor of macrophages in tissue macrophages, leukocytes and vascular endothelial cells of dogs. Tissue and Cell. 2019; 58:112-120
Nakazawa M, Maeda S*, Omori M, Kaji K, Yokoyama N, Nakagawa T, Chambers JK, Uchida K, Ohno K, Yonezawa T, Matsuki N. Duodenal expression of antimicrobial peptides in dogs with idiopathic inflammatory bowel disease and intestinal lymphoma. The Veterinary Journal. 2019; 249:47-52
Maehara T, Nakamura T, Maeda S, Aritake K, Nakamura M, Murata T*. Epithelial cell-derived prostaglandin D2 inhibits chronic allergic lung inflammation in mice. The FASEB Journal. 2019; 33(7):8202-8210
Tsuboi M†, Sakai K†, Maeda S*, Chambers JK, Yonezawa T, Matsuki N, Uchida K, Nakayama H. Assessment of HER2 Expression in Canine Urothelial Carcinoma of the Urinary Bladder. Veterinary Pathology. 2019; 56(3):369-376
2018（7）
Sakai K, Maeda S*, Saeki K, Nakagawa T, Murakami M, Endo Y, Yonezawa T, Kadosawa T, Mori T, Nishimura R, Matsuki N. Anti-tumour effect of lapatinib in canine transitional cell carcinoma cell lines. Veterinary and Comparative Oncology. 2018; 16(4):642-649
Inagaki S†, Maeda S†, Narita M, Nakamura T, Shimosawa T, Murata T*, Ohya Y*. Urinary PGDM, a prostaglandin D2 metabolite, is a novel biomarker for objectively detecting allergic reactions of food allergy. Journal of Allergy and Clinical Immunology. 2018;142(5):1634-1636.e10.
Maeda S*†, Tomiyasu H†, Tsuboi M, Inoue A, Ishihara G, Uchikai T, Chambers JK, Uchida K, Yonezawa T, Matsuki N.
Comprehensive gene expression analysis of canine invasive urothelial bladder carcinoma by RNA-Seq. BMC Cancer. 2018; 18(1):472
Sugimoto S, Maeda S*, Tsuboi M, Saeki K, Chambers JK, Yonezawa T, Fukushima K, Fujiwara R, Uchida K, Tsujimoto H, Matsuki N, Ohno K. Multiple acquired portosystemic shunts secondary to primary hypoplasia of the portal vein in a cat. Journal of Veterinary Medical Science. 2018; 80(6):874-877
Hamabata T, Nakamura T, Masuko S, Maeda S, Murata T*. Production of lipid mediators across different disease stages of dextran sulfate sodium-induced colitis in mice. Journal of Lipid Research. 2018; jlr.M079095
Sakai K, Maeda S*, Yamada Y, Chambers JK, Uchida K, Nakayama H, Yonezawa T, Matsuki N. Association of tumour-infiltrating regulatory T cells with adverse outcomes in dogs with malignant tumours. Veterinary and Comparative Oncology. 2018; 16: 330-336 (ジャーナルの表紙に掲載)
Sakai K, Maeda S*, Yonezawa T, Matsuki N. Decreased plasma amino acid concentrations in cats with chronic gastrointestinal diseases and their possible contribution in the inflammatory response. Veterinary Immunology and Immunopathology. 2018; 195:1-6
2017（5）
Maeda S, Nakamura T, Harada H, Tachibana Y, Aritake K, Shimosawa T, Yatomi Y, Murata T*. Prostaglandin D2 metabolite in urine is an index of food allergy. Scientific Reports. 2017; 15;7(1):17687
Maeda S*, Tsuboi M, Sakai K, Ohno K, Fukushima K, Kanemoto H, Hiyoshi-Kanemoto S, Goto-Koshino Y, Chambers JK, Yonezawa T, Uchida K, Matsuki N. Endoscopic Cytology for the Diagnosis of Chronic Enteritis and Intestinal Lymphoma in Dogs. Veterinary Pathology. 2017; 54(4):595-604
Nakamura T, Fujiwara Y, Yamada R, Fujii W, Hamabata T, Lee MY, Maeda S, Aritake K, Roers A, Sessa WC, Nakamura
M, Urade Y, Murata T*. Mast cell-derived prostaglandin D2 attenuates anaphylactic reactions in mice. Journal of Allergy Clinical Immunology. 2017; 140(2):630-632.e9
Inoue A, Maeda S*, Kinoshita R, Tsuboi M, Yonezawa T, Matsuki N. Density of tumor-infiltrating granzyme B-positive cells predicts favorable prognosis in dogs with transitional cell carcinoma. Veterinary Immunology and Immunopathology. 2017; 190: 53-56
Omori M, Maeda S*, Igarashi H, Ohno K, Sakai K, Yonezawa T, Horigome A, Odamaki T, Matsuki N. Fecal microbiome in dogs with inflammatory bowel disease and intestinal lymphoma. Journal of Veterinary Medical Science. 2017; 17;79(11):1840-1847
2016（5）
Kobayashi K, Horikami D, Omori K, Nakamura T, Yamazaki A, Maeda S, Murata T*. Thromboxane A2 exacerbates acute lung injury via promoting edema formation. Scientific Reports. 2016; 6:32109
Murakami K, Maeda S, Yonezawa T, Matsuki N*. CC chemokine ligand 2 and CXC chemokine ligand 8 as neutrophil chemoattractant factors in canine idiopathic polyarthritis. Veterinary Immunology and Immunopathology. 2016;182: 52-58
Uchida M, Saeki K, Maeda S, Tamahara S, Yonezawa T*, Matsuki N. Apoptosis inhibitor of macrophage (AIM) reduces cell number in canine histiocytic sarcoma cell lines. Journal of Veterinary Medical Science. 2016;78(9): 1515-1520
Murakami K, Maeda S, Yonezawa T, Matsuki N*. Synovial fluid matrix metalloproteinase-2 and -9 activities in dogs suffering from joint disorders. Journal of Veterinary Medical Science. 2016; 78(6): 1051-1054
Maeda S, Ohno K*, Fujiwara-Igarashi A, Uchida K, Tsujimoto H. Changes in Foxp3-positive Treg number in the intestine of dogs with idiopathic inflammatory bowel disease and intestinal lymphoma. Veterinary Pathology. 2016; 53(1): 102-112
2015（4）
Nakamura T, Maeda S, Horiguchi K, Maehara T, Aritake K, Choi BI, Iwakura Y, Urade Y, Murata T*. PGD2 deficiency exacerbates food antigen-induced mast cell hyperplasia. Nature Communications. 2015; 6:7514
Nakashima K, Hiyoshi S, Ohno K*, Uchida K, Goto-Koshino Y, Maeda S, Mizutani N, Takeuchi A,Tsujimoto H. Prognostic factors in dogs with protein-losing enteropathy. Veterinary Journal. 2015; 205(1):28-32.
Hiyoshi S, Ohno K*, Uchida K, Goto-Koshino Y, Nakashima K, Fukushima K, Kanemoto H, Maeda S, Tsujimoto H. Association between lymphocyte antigen receptor gene rearrangements and histopathological evaluation in canine chronic enteropathy. Veterinary Immunology and Immunopathology. 2015; 165(3-4):138-144.
Goto-Koshino Y*, Mochizuki H, Sato M, Nakashima K, Hiyoshi S, Fujiwara-Igarashi A, Maeda S, Nakamura K, Uchida K, Fujino Y, Ohno K, Tsujimoto H. Construction of a multicolor GeneScan analytical system to detect clonal rearrangements of immunoglobulin and T cell receptor genes in canine lymphoid tumors. Veterinary Immunology and Immunopathology. 2015; 165(1-2):81-87.
2014（7）
Igarashi H†, Maeda S†, Ohno K*, Horigome A, Odamaki T, Tsujimoto H. Effect of Oral Administration of Metronidazole or Prednisolone on Fecal Microbiota in Dogs. PLoS One. 2014; 9(9): e107909.
Maeda S, Ohno K*, Uchida K, Igarashi H, Goto-Koshino Y, Fujino Y, Tsujimoto H. Intestinal Protease-Activated Receptor-2 and Fecal Serine Protease Activity are Increased in Canine Inflammatory Bowel Disease and May Contribute to Intestinal Cytokine Expression. Journal of Veterinary Medical Science. 2014; 76(8): 1119-1127. (2014年JVMS優秀論文賞)
Maeda S, Ohno K*, Fujiwara-Igarashi A, Tomiyasu H, Fujino Y, Tsujimoto H. Methylation of TNFRSF13B and TNFRSF13C in duodenal mucosa in canine inflammatory bowel disease and its association with decreased mucosal IgA expression. Veterinary Immunology and Immunopathology. 2014; 160(1-2): 97-106.
Maeda S, Nakamura T, Murata T*. Tumor suppressor prostaglandin D2. Oncoscience. 2014; 1(6): 396-397.
Iwanaga K, Nakamura T, Maeda S, Aritake K, Hori M, Urade Y, Ozaki H, Murata T*. Mast cell-derived PGD2 inhibits colitis and colitis-associated colon cancer in mice. Cancer Research. 2014; 74(11): 3011-3019.
Igarashi H, Ohno K*, Maeda S, Kanemoto H, Fukushima K, Uchida K, Tsujimoto H. Expression profiling of pattern recognition receptors and selected cytokines in miniature dachshunds with inflammatory colorectal polyps. Veterinary Immunology and Immunopathology. 2014; 159(1-2): 1-10.
Fujiwara-Igarashi A, Goto-Koshino Y, Sato M, Maeda S, Igarashi H, Takahashi M, Fujino Y, Tsujimoto H*. Prognostic significance of the expression levels of the p16, p15, and p14 genes in dogs with high-grade lymphoma. The Veterinary Journal. 2014; 199(2): 236-244.
2013（5）
Kubota S, Ohno K*, Tsukamoto A, Maeda S, Murata Y, Nakashima K, Fukushima K, Uchida K, Fujino Y, Tsujimoto H. Value of the 13C-Urea Breath Test for Detection of Gastric Helicobacter spp. Infection in Dogs Undergoing Endoscopic Examination. Journal of Veterinary Medical Science. 2013; 75(8): 1049-1054.
Fujiwara-Igarashi A, Goto-Koshino Y, Mochizuki H, Maeda S, Fujino Y, Ohno K, Tsujimoto H*. Simultaneous Inactivation of the p16, p15 and p14 Genes Encoding Cyclin-Dependent Kinase Inhibitors in Canine T-Lymphoid Tumor Cells. Journal of Veterinary Medical Science. 2013; 75: 733-42.
Maeda S, Maeda S, Ohno K*, Kaji N, Hori M, Fujino Y, Tsujimoto H. Protease-activated receptor-2 induces proinflammatory cytokine and chemokine gene expression in canine keratinocytes. Veterinary Immunology and Immunopathology. 2013; 153: 17-25.
Maeda S, Ohno K*, Uchida K, Nakashima K, Fukushima K, Tsukamoto A, Nakajima M, Fujino Y, Tsujimoto H. Decreased immunoglobulin A concentrations in feces, duodenum, and peripheral blood mononuclear cells of dogs with inflammatory bowel disease. Journal of Veterinary Internal Medicine. 2013; 27: 47-55.
Maeda S, Fujino Y*, Tamamoto C, Suzuki S, Fujita A, Takahashi M, Ohno K, Uchida K, Tsujimoto H. Lymphangiomatosis of the systemic skin in an old dog. Journal of Veterinary Medical Science. 2013; 75: 187-190.
2012（6）
Maeda S, Ohno K*, Nakamura K, Uchida K, Nakashima K, Fukushima K, Nakajima M, Goto-Koshino Y, Fujino Y, Tsujimoto H. Increased expression of fractalkine and its receptor CX3CR1 in canine inflammatory bowel disease and their possible role in recruitment of intraepithelial lymphocytes. Veterinary Immunology and Immunopathology. 2012; 148: 226-235.
Maeda S, Ohno K*, Nakamura K, Uchida K, Nakashima K, Fukushima K, Tsukamoto A, Goto-Koshino Y, Fujino Y, Tsujimoto H. Mucosal imbalance of interleukin-1beta and interleukin-1 receptor antagonist in canine inflammatory bowel disease. The Veteryanry Journal. 2012; 194: 66-70.
Tsukamoto A, Ohno K*, Maeda S, Nakashima K, Fukushima K, Fujino Y, Hori M, Tsujimoto H. Effect of mosapride on prednisolone-induced gastric mucosal injury and gastric-emptying disorder in dogs. Journal of Veterinary Medical Science. 2012; 74: 1103-1108.
Maeda S, Ohno K*, Tsukamoto A, Nakashima K, Fukushima K, Goto-Koshino Y, Fujino Y, Tsujimoto H. Molecular cloning and expression analysis of the canine chemokine receptor CCR9. Veterinary Immunology and Immunopathology. 2012; 145: 534-539.
Maeda S, Ohno K*, Nakashima K, Fukushima K, Tsukamoto A, Suzuki H, Fujiwara A, Goto-Koshino Y, Fujino Y, Tsujimoto H. Molecular cloning and characterization of canine fractalkine and its receptor CX3CR1. Veterinary Immunology and Immunopathology. 2012; 145: 100-109.
Tsukamoto A, Ohno K*, Irie M, Ohmi A, Maeda S, Nakashima K, Fukushima K, Fujino Y, Uchida K, Tsujimoto H. A Case of Canine Multiple Inflammatory Colorectal Polyps Treated by Endoscopic Polypectomy and Argon Plasma Coagulation. Journal of Veterinary Medical Science. 2012; 74: 503-506.
2011（4）
Tsukamoto A, Ohno K*, Maeda S, Nakashima K, Fukushima K, Fujino Y, Tsujimoto H. Prokinetic effect of the 5-HT4R agonist mosapride on canine gastric motility. Journal of Veterinary Medical Science. 2011; 73: 1635-1637.
Tsukamoto A, Ohno K*, Tsukagoshi T, Maeda S, Nakashima K, Fukushima K, Fujino Y, Takeuchi A, Tsujimoto H. Ultrasonographic evaluation of vincristine-induced gastric hypomotility and the prokinetic effect of mosapride in dogs. Journal of Veterinary Internal Medicine. 2011; 25: 1461-1464.
Tsukamoto A, Ohno K, Tsukagoshi T, Maeda S, Nakashima K, Fukushima K, Fujino Y, Tsujimoto H. Real-time ultrasonographic evaluation of canine gastric motility in the postprandial state. Journal of Veterinary Medical Science. 2011; 73: 1133-1138.
Maeda S, Ohno K*, Nakamura K, Uchida K, Nakashima K, Fukushima K, Tsukamoto A, Goto-Koshino Y, Fujino Y, Tsujimoto H. Quantification of chemokine and chemokine receptor gene expression in duodenal mucosa of dogs with inflammatory bowel disease. Veterinary Immunology and Immunopathology. 2011; 144: 290-298.
～2010（4）
Shibata S, Maeda S*, Maeda S, Chimura N, Kondo N, Fukata T. Augmentation of CCL17 and CCL28 gene expression by TNF-alpha, IL-1beta, or IFN-gamma in cultured canine keratinocytes. Research in Veterinary Science. 2010; 88: 422-426.
Shibata S, Maeda S*, Kondo N, Inoue A, Maeda S, Chimura N, Fukata T. Effect of recombinant canine interferon-gamma on granulocyte-macrophage colony-stimulating factor, transforming growth factor-beta and CC chemokine ligand 17 mRNA transcription in a canine keratinocyte cell line (CPEK). Veterinary Dermatology. 2010; 22: 24-30.
Maeda S, Maeda S*, Shibata S, Chimura N, Fukata T. Molecular cloning of canine protease-activated receptor-2 and its expression in normal dog tissues and atopic skin lesions. Journal of Veterinary Medical Science. 2009; 71: 577-582.
Maeda S, Maeda S*, Shibata S, Chimura N, Fukata T. House dust mite major allergen Der f 1 enhances proinflammatory cytokine and chemokine gene expression in a cell line of canine epidermal keratinocytes. Veterinary Immunology and Immunopathology. 2009; 131: 298-302.